CSI Market
Sign In | Register

Arcus Biosciences Inc (RCUS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RCUS Annual Balance Sheets →
Examining balance sheet movements between Arcus Biosciences Inc and Sep 30 2025 reveals how Sep 30 2026 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/RCUS/balance-sheets
https://api.csimarket.com/api/v1/companies/RCUS/fundamentals
https://api.csimarket.com/api/v1/companies/RCUS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent151.00
Cash, Cash Equivalents Other0.00
Combined Cash+Investments Total (filer-reported)694.00
Restricted Cash3.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments151.00
Interest Receivable, Current5.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current16.00
Total Current Assets664.00
Equipment/Property/Plant Net33.00
Long-term investments64.00
Other Assets, Noncurrent546.00
Contract With Customer Asset Net Current3.00
Total Assets818.00
Liabilities
Accounts Payable, Current AC44.00
Accrued Liabilities, Current AC28.00
Other Liabilities, Current126.00
Taxes Payable1.00
Total Current Liabilities199.00
Long-term debt102.00
Total Long-term Debt102.00
Other liabilities, Noncurrent159.00
Contract With Customer Liability Current34.00
Contract With Customer Liability Noncurrent45.00
Total Liabilities460.00
Stockholders' Equity
Common Stock Value2,192.00
Retained Earnings / Accumulated Deficit-1,832.00
Accumulated Other Comprehensive Income-2.00
Other Equity-2.00
Common Stockholder's Equity358.00
Total Stockholder's Equity358.00
Liabilities & Stockholder's Equity818.00
4 historic quarters locked

Sign in to unlock the full Arcus Biosciences Inc balance sheet history.

Sign In Create Free Account

About Arcus Biosciences Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001724521-26-000058

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI